Aldeyra Therapeutics Inc (ALDX)
4.81
+0.05
(+1.05%)
USD |
NASDAQ |
Nov 21, 16:00
4.82
+0.01
(+0.21%)
After-Hours: 20:00
Aldeyra Therapeutics Total Assets (Quarterly): 117.32M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 117.32M |
| June 30, 2024 | 126.04M |
| March 31, 2024 | 141.30M |
| December 31, 2023 | 148.33M |
| September 30, 2023 | 147.28M |
| June 30, 2023 | 155.62M |
| March 31, 2023 | 168.22M |
| December 31, 2022 | 181.29M |
| September 30, 2022 | 189.69M |
| June 30, 2022 | 201.02M |
| March 31, 2022 | 222.69M |
| December 31, 2021 | 233.14M |
| September 30, 2021 | 247.22M |
| June 30, 2021 | 256.43M |
| March 31, 2021 | 147.31M |
| December 31, 2020 | 83.35M |
| September 30, 2020 | 88.32M |
| June 30, 2020 | 71.63M |
| March 31, 2020 | 63.03M |
| December 31, 2019 | 75.52M |
| September 30, 2019 | 77.44M |
| June 30, 2019 | 73.84M |
| March 31, 2019 | 88.13M |
| Date | Value |
|---|---|
| December 31, 2018 | 95.09M |
| September 30, 2018 | 37.13M |
| June 30, 2018 | 43.29M |
| March 31, 2018 | 40.78M |
| December 31, 2017 | 44.18M |
| September 30, 2017 | 49.23M |
| June 30, 2017 | 26.47M |
| March 31, 2017 | 31.53M |
| December 31, 2016 | 25.19M |
| September 30, 2016 | 29.19M |
| June 30, 2016 | 32.88M |
| March 31, 2016 | 23.44M |
| December 31, 2015 | 28.20M |
| September 30, 2015 | 31.35M |
| June 30, 2015 | 33.88M |
| March 31, 2015 | 15.93M |
| December 31, 2014 | 8.787M |
| September 30, 2014 | 10.35M |
| June 30, 2014 | 11.81M |
| March 31, 2014 | 2.891M |
| December 31, 2013 | 3.743M |
| September 30, 2013 | 2.819M |
| December 31, 2012 | 1.977M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
63.03M
Minimum
Mar 2020
256.43M
Maximum
Jun 2021
153.24M
Average
147.82M
Median
Total Assets (Quarterly) Benchmarks
| AbbVie Inc | 143.42B |
| NovaBay Pharmaceuticals Inc | 3.877M |
| Palatin Technologies Inc | 3.415M |
| iBio Inc | 24.52M |
| Theriva Biologics Inc | 40.11M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 32.22M |
| Shareholders Equity (Quarterly) | 85.10M |